Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$5.8 - $8.02 $2,900 - $4,010
-500 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$6.87 - $9.16 $3,435 - $4,580
500 New
500 $4,000
Q1 2021

May 24, 2021

SELL
$7.67 - $13.77 $3,835 - $6,885
-500 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$14.16 - $19.45 $7,080 - $9,725
500 New
500 $8,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $146M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.